79
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Preoperative fasting hyperglycemia is an independent prognostic factor for postoperative survival after gallbladder carcinoma radical surgery

, , , &
Pages 1425-1432 | Published online: 12 Feb 2019

References

  • Lazcano-PonceECMiquelJFMuñozNEpidemiology and molecular pathology of gallbladder cancerCA Cancer J Clin200151634936411760569
  • LeganMCyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomasBosn J Basic Med Sci201010319219620846124
  • XuWYZhangHHYangXBPrognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patientsWorld J Gastroenterol201824131451146329632426
  • HuMTWangJHYuYTumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancyInt J Oncol20185331215122630015925
  • ChenYWuFSaitoEAssociation between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia cohort ConsortiumDiabetologia20176061022103228265721
  • SheblFMAndreottiGRashidADiabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, ChinaBr J Cancer2010103111511920517308
  • GiovannucciEHarlanDMArcherMCDiabetes and cancer: a consensus reportDiabetes Care20103371674168520587728
  • DoSKJeongJYLeeSYGlucose transporter 1 gene variants predict the prognosis of patients with early-stage non-small cell lung cancerAnn Surg Oncol201825113396340330062472
  • LamkinDMSpitzDRShahzadMMGlucose as a prognostic factor in ovarian carcinomaCancer200911551021102719156916
  • ParkSMLimMKShinSAYunYHImpact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation StudyJ Clin Oncol200624315017502417075121
  • KawamuraTKusakabeTSuginoTExpression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survivalCancer200192363464111505409
  • NoguchiYMaratDSaitoAExpression of facilitative glucose transporters in gastric tumorsHepatogastroenterology199946282683268910522065
  • HaberRSRathanAWeiserKRGLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosisCancer199883134409655290
  • LeganMTevžičSTolarALuzarBMaroltVFGlucose transporter-1 (GLUT-1) immunoreactivity in benign, premalignant and malignant lesions of the gallbladderPathol Oncol Res2011171616620512538
  • PangQZhangLQWangRTPlatelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinomaWorld J Gastroenterol201521216675668326074706
  • KanthanRSengerJLAhmedSKanthanSCGallbladder cancer in the 21st centuryJ Oncol2015201510126
  • ZhuAXHongTSHezelAFKoobyDACurrent management of gallbladder carcinomaOncologist201015216818120147507
  • CaiQLuoXLiangYFasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal typeBr J Cancer2013108238038623299534
  • LuoJChenYJChangLJFasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patientsLung Cancer201276224224722112292
  • HundalRShafferEAGallbladder cancer: epidemiology and outcomeClin Epidemiol201469910924634588
  • ShenHXSongHWXuXJClinical epidemiological survey of gallbladder carcinoma in northwestern China, 2009-2013: 2379 cases in 17 centersChronic Dis Transl Med201731606629063057
  • HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
  • SuhSKimKWDiabetes and cancer: is diabetes causally related to cancer?Diabetes Metab J201135319319821785737
  • GiovannucciEInsulinGEInsulin, insulin-like growth factors and colon cancer: a review of the evidenceJ Nutr200113111 Suppl3109S312011694656
  • CookKDBorzokJSumreinFOplerDJEvaluation and perioperative management of the diabetic patientClin Podiatr Med Surg20193618310230446046
  • HeindelJJBlumbergBCaveMMetabolism disrupting chemicals and metabolic disordersReprod Toxicol20176833327760374
  • MasurKVetterCHinzADiabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferationBr J Cancer2011104234535221179032
  • DuanWShenXLeiJHyperglycemia, a neglected factor during cancer progressionBiomed Res Int201420144176110
  • YoungCDAndersonSMSugar and fat – that’s where it’s at: metabolic changes in tumorsBreast Cancer Res200810120218304378
  • RudlowskiCMoserMBeckerAJGLUT1 mRNA and protein expression in ovarian borderline tumors and cancerOncology200466540441015331928
  • KrzeslakAWojcik-KrowirandaKFormaEExpression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancersPathol Oncol Res201218372172822270867
  • KroneCAElyJTControlling hyperglycemia as an adjunct to cancer therapyIntegr Cancer Ther200541253115695475
  • RyuTYParkJSchererPEHyperglycemia as a risk factor for cancer progressionDiabetes Metab J201438533033625349819
  • PiątkiewiczPCzechAGlucose metabolism disorders and the risk of cancerArch Immunol Ther Exp (Warsz)201159321523021448680
  • HanJZhangLGuoHGlucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signalingGynecol Oncol2015138366867526135947
  • ChenJYuYChenXmiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinomaCell Prolif2018516e1251030105813